Skip to main content

Evaluation of the effects of Glycanics on experimental allergic asthma

Project Member(s): Hansbro, P.

Funding or Partner Organisation: Glycosynnovations Pty Ltd
Glycosynnovations Pty Ltd

Start year: 2020

Summary: The overall aim is to study the therapeutic effects of candidate heparin mimetic drugs (Generation 3 compounds) on the late phase of allergic inflammatory responses and airway hyperresponsiveness (AHR) in a mouse model of allergic asthma. The particular target is Th2 disease and eosinophils.

FOR Codes: Immune System and Allergy, Cardiorespiratory Medicine and Haematology, Cardiovascular medicine and haematology, Clinical health